高雄醫學大學圖書館 |

語系/ Language: 繁體中文

登入

回首頁

NAFLD Surveillance in the Alaska Nat...

Walden University.

NAFLD Surveillance in the Alaska Native/American Indian Population /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	NAFLD Surveillance in the Alaska Native/American Indian Population // Wileina Saumara Rhodes.
作者:	Rhodes, Wileina Saumara,
面頁冊數:	1 electronic resource (125 pages)
附註:	Source: Dissertations Abstracts International, Volume: 86-12, Section: A.
提要註:	In the United States, the prevalence of NAFLD is estimated at 24% of the population, and by 2030, the incidence of NAFLD will increase to 100.9 million cases. This study aimed to determine the prevalence and rate of non-alcoholic fatty liver disease (NAFLD) progression in the Alaska Native/ American Indian population (AN/AI) with and without elevated liver function tests. Two research questions guided the study: Do outcomes (abnormal/normal) of LFTs, A1C, lipids, BMI, and inflammatory markers predict or have a relationship with NAFLD progression? Does NAFLD surveillance have a relationship with the patient's outcome as measured by the NAFLD Fibrosis score and FibroScan CAP Score? The theoretical approaches to this study were the transtheoretical model and the health belief model. A quantitative correlational design was used, requiring a minimum sample size of at least 92 participants. Secondary data were obtained from the Alaska Native Tribal Health Consortium Liver Disease and Hepatitis Program database. The inclusion criteria of the study were AN/AI patients with NAFLD. The results of the study indicated that ALT, AST, and Steatohepatitis were significant predictors of NAFLD Fibrosis score. An increase in A1C, triglycerides, and BMI corresponded with an increase in CAP Scores, while an abnormal AST level corresponded to a decrease in CAP Scores. Plasma ALT evaluation resulted in a decrease in NALFD incidence rates. Various organizations may adopt these study findings to help them in formulating guidelines that will help them in educating the members of the public on risk factors of NAFLD, as well as advocate for appropriate mechanisms in mitigating them. .
Contained By:	Dissertations Abstracts International86-12A.
標題:	Native American studies. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=32113731
ISBN:	9798280755512

NAFLD Surveillance in the Alaska Native/American Indian Population /
Rhodes, Wileina Saumara,

NAFLD Surveillance in the Alaska Native/American Indian Population /Wileina Saumara Rhodes. - 1 electronic resource (125 pages)

Source: Dissertations Abstracts International, Volume: 86-12, Section: A.

In the United States, the prevalence of NAFLD is estimated at 24% of the population, and by 2030, the incidence of NAFLD will increase to 100.9 million cases. This study aimed to determine the prevalence and rate of non-alcoholic fatty liver disease (NAFLD) progression in the Alaska Native/ American Indian population (AN/AI) with and without elevated liver function tests. Two research questions guided the study: Do outcomes (abnormal/normal) of LFTs, A1C, lipids, BMI, and inflammatory markers predict or have a relationship with NAFLD progression? Does NAFLD surveillance have a relationship with the patient's outcome as measured by the NAFLD Fibrosis score and FibroScan CAP Score? The theoretical approaches to this study were the transtheoretical model and the health belief model. A quantitative correlational design was used, requiring a minimum sample size of at least 92 participants. Secondary data were obtained from the Alaska Native Tribal Health Consortium Liver Disease and Hepatitis Program database. The inclusion criteria of the study were AN/AI patients with NAFLD. The results of the study indicated that ALT, AST, and Steatohepatitis were significant predictors of NAFLD Fibrosis score. An increase in A1C, triglycerides, and BMI corresponded with an increase in CAP Scores, while an abnormal AST level corresponded to a decrease in CAP Scores. Plasma ALT evaluation resulted in a decrease in NALFD incidence rates. Various organizations may adopt these study findings to help them in formulating guidelines that will help them in educating the members of the public on risk factors of NAFLD, as well as advocate for appropriate mechanisms in mitigating them. .

English

ISBN: 9798280755512Subjects--Topical Terms:

524069
Native American studies.
Subjects--Index Terms:

Non-alcoholic fatty liver disease

NAFLD Surveillance in the Alaska Native/American Indian Population /
LDR:03190nam a22004573i 4500 001 391499
005 20251124054807.5
006 m o d
007 cr|nu||||||||
008 251208s2025 miu||||||m |||||||eng d
020 $a 9798280755512
035 $a (MiAaPQD)AAI32113731
035 $a AAI32113731
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Rhodes, Wileina Saumara, $e author. $3 524067
245 1 0 $a NAFLD Surveillance in the Alaska Native/American Indian Population / $c Wileina Saumara Rhodes.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2025
300 $a 1 electronic resource (125 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-12, Section: A.
500 $a Advisors: Mori, Naoyo; Miller, Leah.
502 $b Ph.D. $c Walden University $d 2025.
520 $a In the United States, the prevalence of NAFLD is estimated at 24% of the population, and by 2030, the incidence of NAFLD will increase to 100.9 million cases. This study aimed to determine the prevalence and rate of non-alcoholic fatty liver disease (NAFLD) progression in the Alaska Native/ American Indian population (AN/AI) with and without elevated liver function tests. Two research questions guided the study: Do outcomes (abnormal/normal) of LFTs, A1C, lipids, BMI, and inflammatory markers predict or have a relationship with NAFLD progression? Does NAFLD surveillance have a relationship with the patient's outcome as measured by the NAFLD Fibrosis score and FibroScan CAP Score? The theoretical approaches to this study were the transtheoretical model and the health belief model. A quantitative correlational design was used, requiring a minimum sample size of at least 92 participants. Secondary data were obtained from the Alaska Native Tribal Health Consortium Liver Disease and Hepatitis Program database. The inclusion criteria of the study were AN/AI patients with NAFLD. The results of the study indicated that ALT, AST, and Steatohepatitis were significant predictors of NAFLD Fibrosis score. An increase in A1C, triglycerides, and BMI corresponded with an increase in CAP Scores, while an abnormal AST level corresponded to a decrease in CAP Scores. Plasma ALT evaluation resulted in a decrease in NALFD incidence rates. Various organizations may adopt these study findings to help them in formulating guidelines that will help them in educating the members of the public on risk factors of NAFLD, as well as advocate for appropriate mechanisms in mitigating them. .
546 $a English
590 $a School code: 0543
650 4 $a Native American studies. $3 524069
650 4 $2 96060 $a Medicine. $3 219985
650 4 $2 96060 $a Public health. $3 206087
650 4 $2 96060 $a Epidemiology. $3 215933
653 $a Non-alcoholic fatty liver disease
653 $a Alaska Native/ American Indian
653 $a Population
653 $a Fibrosis score
653 $a Steatohepatitis
690 $a 0766
690 $a 0564
690 $a 0740
690 $a 0573
710 2 $a Walden University. $b Public Health. $e degree granting institution. $3 524068
720 1 $a Mori, Naoyo $e degree supervisor.
720 1 $a Miller, Leah $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-12A.
790 $a 0543
791 $a Ph.D.
792 $a 2025
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=32113731

筆 0 讀者評論

多媒體

評論

新增評論分享你的心得，請勿在此評論區張貼涉及人身攻擊、情緒謾罵、或內容涉及非法的不當言論，館方有權利刪除任何違反評論規則之發言，情節嚴重者一律停權，以維護所有讀者的自由言論空間。

Export

取書館別